A detailed history of Avalon Trust CO transactions in Moderna, Inc. stock. As of the latest transaction made, Avalon Trust CO holds 314 shares of MRNA stock, worth $7,774. This represents 0.0% of its overall portfolio holdings.

Number of Shares
314
Holding current value
$7,774
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 10, 2025

BUY
$23.51 - $34.67 $7,382 - $10,886
314 New
314 $8.11 Million
Q1 2023

May 11, 2023

BUY
$135.66 - $197.02 $315,545 - $458,268
2,326 New
2,326 $357 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $9.69B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Avalon Trust CO Portfolio

Follow Avalon Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avalon Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Avalon Trust CO with notifications on news.